Cancer Drug News Do certain diabetes drugs increase the risk of acute kidney injury in patients taking anti-cancer therapies?
Protected: Tecartus® (Brexucabtagene Autoleucel) CAR T-cell therapy now funded in Australia for adult relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (r/r ALL)
Cancer Drug News Non-profit drug development could cut cost of cancer medicines February 11, 2017 Universities should work with new forms of commercial partner to take their own cancer drugs…
Cancer Drug News Cancer drug prices must come down, say leading international research institutes February 9, 2017 By Sarah Boseley – The Guardian. Top UK and US scientists say high cost for…
Cancer Drug News Ovarian cancer drug ‘most significant’ PBS listing in 30 years February 7, 2017 SBS The quality of life for hundreds of women with advanced ovarian cancer is set…
Breast Cancer Immunotherapy: Training the body to fight cancer February 7, 2017 Balveen Kaur, The Ohio State University and Pravin Kaumaya, The Ohio State University The human…
Cancer Drug News Androgen deprivation therapy not associated with increased risk of Alzheimer’s disease January 31, 2017 A large-scale, population based study led by Dr. Laurent Azoulay, Senior Investigator with the Lady…
Cancer Drug News Study establishes new standard of care for pancreatic cancer patients January 31, 2017 A combination of two chemotherapy drugs – gemcitabine and capecitabine – should be the new standard of care for…
Cancer Drug News Malaria drug successfully treats 26-year-old brain cancer patient January 24, 2017 The anti-autophagy drug chloroquine may be a unique way to re-sensitise some cancer patients to…
Cancer Drug News Nivolumab boosts 12mo survival rates in gastric cancer trial January 20, 2017 The results of trial ONO-4538-12 were announced today, demonstrating nivolumab significantly reduced the risk of…
Cancer Drug News Financial ties between researchers and drug industry linked to positive trial results January 20, 2017 Financial ties between researchers and companies that make the drugs they are studying are independently…
Cancer Drug News New drug in development shows improved progression-free survival for patients with advanced metastatic midgut neuroendocrine tumours January 19, 2017 A new therapy in development for the treatment of midgut neuroendocrine tumours, a rare type…